January 7, 2026- A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)— even on days when mealtime boluses were missed. CareLink™ data showed that the studied user population achieved 76.3% TIR on missed bolus days when using SmartGuard™ technology with recommended optimal settings (100 mg/dL glucose target; two-hour active insulin time). The study investigated off-label user behavior as the system labeling requires users to announce meals when using SmartGuard™ technology. Deliberately not bolusing is an unapproved use of the device and is not recommended. While meal announcement is required, this study highlights the importance of optimized settings, especially when some users occasionally missed boluses.